Study on the efficacy, safety, and biomarkers of nusinersen in type II and III spinal muscular atrophy in children

MLA

Liyuan Chen, et al. “Study on the Efficacy, Safety, and Biomarkers of Nusinersen in Type II and III Spinal Muscular Atrophy in Children.” Frontiers in Pediatrics, vol. 11, Dec. 2023. EBSCOhost, https://doi.org/10.3389/fped.2023.1294405.

APA

Liyuan Chen, Fen Liu, Danna Fang, & Jianwei Li. (2023). Study on the efficacy, safety, and biomarkers of nusinersen in type II and III spinal muscular atrophy in children. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1294405

Chicago

Liyuan Chen, Fen Liu, Danna Fang, and Jianwei Li. 2023. “Study on the Efficacy, Safety, and Biomarkers of Nusinersen in Type II and III Spinal Muscular Atrophy in Children.” Frontiers in Pediatrics 11 (December). doi:10.3389/fped.2023.1294405.